Sponsor Pipeline

Diakonos Oncology Corporation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06805305 DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma… Glioblastoma (GBM) Recruiting
Phase 1/2
NCT07288112 DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma Refractory Melanoma Recruiting
Phase 1
NCT04157127 Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma Pancreatic Adenocarcinoma Recruiting
Disease Areas
Pancreatic Cancer (1) Glioblastoma (1) Melanoma (1)
Get alerts when Diakonos Oncology Corporation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free